126 related articles for article (PubMed ID: 16455651)
1. A growth-suppressive function for the c-fes protein-tyrosine kinase in colorectal cancer.
Delfino FJ; Stevenson H; Smithgall TE
J Biol Chem; 2006 Mar; 281(13):8829-35. PubMed ID: 16455651
[TBL] [Abstract][Full Text] [Related]
2. Regulation of c-Fes tyrosine kinase activity by coiled-coil and SH2 domains: analysis with Saccharomyces cerevisiae.
Takashima Y; Delfino FJ; Engen JR; Superti-Furga G; Smithgall TE
Biochemistry; 2003 Apr; 42(12):3567-74. PubMed ID: 12653561
[TBL] [Abstract][Full Text] [Related]
3. Promoter methylation blocks FES protein-tyrosine kinase gene expression in colorectal cancer.
Shaffer JM; Smithgall TE
Genes Chromosomes Cancer; 2009 Mar; 48(3):272-84. PubMed ID: 19051325
[TBL] [Abstract][Full Text] [Related]
4. A point mutation in the N-terminal coiled-coil domain releases c-Fes tyrosine kinase activity and survival signaling in myeloid leukemia cells.
Cheng HY; Schiavone AP; Smithgall TE
Mol Cell Biol; 2001 Sep; 21(18):6170-80. PubMed ID: 11509660
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the human c-fes protein tyrosine kinase (p93c-fes) by its src homology 2 domain and major autophosphorylation site (Tyr-713).
Hjermstad SJ; Peters KL; Briggs SD; Glazer RI; Smithgall TE
Oncogene; 1993 Aug; 8(8):2283-92. PubMed ID: 7687763
[TBL] [Abstract][Full Text] [Related]
6. Src homology 2 domain substitution modulates the kinase and transforming activities of the Fes protein-tyrosine kinase.
Rogers JA; Cheng HY; Smithgall TE
Cell Growth Differ; 2000 Nov; 11(11):581-92. PubMed ID: 11095247
[TBL] [Abstract][Full Text] [Related]
7. Autophosphorylation of the Fes tyrosine kinase. Evidence for an intermolecular mechanism involving two kinase domain tyrosine residues.
Rogers JA; Read RD; Li J; Peters KL; Smithgall TE
J Biol Chem; 1996 Jul; 271(29):17519-25. PubMed ID: 8663427
[TBL] [Abstract][Full Text] [Related]
8. The KRAB-associated co-repressor KAP-1 is a coiled-coil binding partner, substrate and activator of the c-Fes protein tyrosine kinase.
Delfino FJ; Shaffer JM; Smithgall TE
Biochem J; 2006 Oct; 399(1):141-50. PubMed ID: 16792528
[TBL] [Abstract][Full Text] [Related]
9. Activation of STAT3 by the c-Fes protein-tyrosine kinase.
Nelson KL; Rogers JA; Bowman TL; Jove R; Smithgall TE
J Biol Chem; 1998 Mar; 273(12):7072-7. PubMed ID: 9507017
[TBL] [Abstract][Full Text] [Related]
10. Bimolecular fluorescence complementation demonstrates that the c-Fes protein-tyrosine kinase forms constitutive oligomers in living cells.
Shaffer JM; Hellwig S; Smithgall TE
Biochemistry; 2009 Jun; 48(22):4780-8. PubMed ID: 19382747
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of the ras GTPase-activating protein (GAP) by the p93c-fes protein-tyrosine kinase in vitro and formation of GAP-fes complexes via an SH2 domain-dependent mechanism.
Hjermstad SJ; Briggs SD; Smithgall TE
Biochemistry; 1993 Oct; 32(39):10519-25. PubMed ID: 7691175
[TBL] [Abstract][Full Text] [Related]
12. Effect of the mutation of tyrosine 713 in p93c-fes on its catalytic activity and ability to promote myeloid differentiation in K562 cells.
Fang F; Ahmad S; Lei J; Klecker RW; Trepel JB; Smithgall TE; Glazer RI
Biochemistry; 1993 Jul; 32(27):6995-7001. PubMed ID: 8334128
[TBL] [Abstract][Full Text] [Related]
13. The role of c-Fes in vascular endothelial growth factor-A-mediated signaling by endothelial cells.
Kanda S; Mochizuki Y; Miyata Y; Kanetake H
Biochem Biophys Res Commun; 2003 Jul; 306(4):1056-63. PubMed ID: 12821150
[TBL] [Abstract][Full Text] [Related]
14. Regulation of c-Fes tyrosine kinase and biological activities by N-terminal coiled-coil oligomerization domains.
Cheng H; Rogers JA; Dunham NA; Smithgall TE
Mol Cell Biol; 1999 Dec; 19(12):8335-43. PubMed ID: 10567558
[TBL] [Abstract][Full Text] [Related]
15. FES/FER kinase signaling in hematopoietic cells and leukemias.
Craig AW
Front Biosci (Landmark Ed); 2012 Jan; 17(3):861-75. PubMed ID: 22201778
[TBL] [Abstract][Full Text] [Related]
16. The c-Fes tyrosine kinase cooperates with the breakpoint cluster region protein (Bcr) to induce neurite extension in a Rac- and Cdc42-dependent manner.
Laurent CE; Smithgall TE
Exp Cell Res; 2004 Sep; 299(1):188-98. PubMed ID: 15302586
[TBL] [Abstract][Full Text] [Related]
17. The human c-Fes tyrosine kinase binds tubulin and microtubules through separate domains and promotes microtubule assembly.
Laurent CE; Delfino FJ; Cheng HY; Smithgall TE
Mol Cell Biol; 2004 Nov; 24(21):9351-8. PubMed ID: 15485904
[TBL] [Abstract][Full Text] [Related]
18. Co-expression with BCR induces activation of the FES tyrosine kinase and phosphorylation of specific N-terminal BCR tyrosine residues.
Li J; Smithgall TE
J Biol Chem; 1996 Dec; 271(51):32930-6. PubMed ID: 8955135
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of the c-Fes protein-tyrosine kinase inhibits the proliferation of human renal carcinoma cells.
Kanda S; Miyata Y; Kanetake H; Smithgall TE
Int J Oncol; 2009 Jan; 34(1):89-96. PubMed ID: 19082481
[TBL] [Abstract][Full Text] [Related]
20. The c-Fes protein-tyrosine kinase suppresses cytokine-independent outgrowth of myeloid leukemia cells induced by Bcr-Abl.
Lionberger JM; Smithgall TE
Cancer Res; 2000 Feb; 60(4):1097-103. PubMed ID: 10706130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
